Clinical Trial Update: Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hetrombopag for thrombocytopenia induced by concurrent chemoradiotherapy; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Hetrombopag (hetrombopag)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Thrombocytopenia, Radiotherapy Side Effect | Phase 2 | Status: RECRUITING